Search results for "Dysplastic"

showing 10 items of 90 documents

Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group

2021

Haematologica : journal of the European Hematology Association 106(5), 1390-1400 (2021). doi:10.3324/haematol.2019.244780

Oncologymedicine.medical_specialtyArticle03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansCumulative incidence030304 developmental biology0303 health sciencesChildhood Cancer RegistryUnivariate analysisbusiness.industryIncidenceLymphoma Non-HodgkinMyelodysplastic syndromesIncidence (epidemiology)Lymphoblastic lymphomaMyeloid leukemiaNeoplasms Second PrimaryHematologyPrecursor Cell Lymphoblastic Leukemia-Lymphomamedicine.diseaseLymphoma030220 oncology & carcinogenesisFemaleCranial Irradiationbusiness
researchProduct

An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults

2015

Abstract Myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN) are hematologically diverse stem cell malignancies sharing phenotypic features of both myelodysplastic syndromes and myeloproliferative neoplasms. There are currently no standard treatment recommendations for most adult patients with MDS/MPN. To optimize efforts to improve the management and disease outcomes, it is essential to identify meaningful clinical and biologic end points and standardized response criteria for clinical trials. The dual dysplastic and proliferative features in these stem cell malignancies define their uniqueness and challenges. We propose response assessment guidelines to harmonize future…

Oncologymedicine.medical_specialtyInternational CooperationImmunologyMEDLINEMedical OncologyBiochemistryMyeloproliferative DisordersSurveys and QuestionnairesInternal medicinehemic and lymphatic diseasesmedicineHumansResponse criteriaCell ProliferationClinical Trials as TopicMyeloproliferative DisordersAdult patientsSurrogate endpointbusiness.industryStandard treatmentMyelodysplastic syndromesfood and beveragesCell BiologyHematologymedicine.diseaseClinical trialPhenotypeTreatment OutcomeHematologic NeoplasmsMyelodysplastic SyndromesMutationPractice Guidelines as TopicDisease ProgressionPhysical therapybusinessAlgorithmsPerspectives
researchProduct

Pevonedistat (PEV) + Azacitidine (AZA) Versus AZA Alone As First-Line Treatment for Patients with Higher-Risk Myelodysplastic Syndromes (MDS)/Chronic…

2021

Abstract Background: Older patients with higher-risk MDS/CMML or AML with 20-30% marrow blasts typically receive single-agent hypomethylating agent (HMA) therapy. Median response duration and survival for these patients is poor, and many patients with MDS transform to secondary AML, which is associated with a particularly dismal prognosis. Novel HMA-based combination therapies that improve survival, delay transformation to AML, and increase depth and duration of response vs single-agent HMA therapy without additional toxicity or myelosuppression are needed. In a randomized, proof-of-concept phase 2 study PEV - a first-in-class, selective inhibitor of NEDD8-activating enzyme - in combination…

Oncologymedicine.medical_specialtybusiness.industryMyelodysplastic syndromesImmunologyAzacitidineChronic myelomonocytic leukemiaMyeloid leukemiaCell BiologyHematologymedicine.diseaseBiochemistryFirst line treatmentInternal medicinemedicinebusinessmedicine.drugBlood
researchProduct

Osteodysplastic primordial dwarfism (ODPD): notes on brain imaging

1998

Pathologymedicine.medical_specialtyNeuroimagingmedicineOsteodysplastic primordial dwarfismBiologyGenetics (clinical)American Journal of Medical Genetics
researchProduct

Editorial for “Quantification of Bone Marrow Fat Fraction and Iron by MRI for Distinguishing Aplastic Anemia and Myelodysplastic Syndromes”

2021

Pathologymedicine.medical_specialtybusiness.industryMyelodysplastic syndromesIronAnemia Aplasticmedicine.diseaseMagnetic Resonance ImagingText miningmedicine.anatomical_structureBone MarrowMyelodysplastic SyndromesmedicineHumansRadiology Nuclear Medicine and imagingBone marrowAplastic anemiabusinessFat fraction
researchProduct

Evans’ Syndrome: From Diagnosis to Treatment

2020

Evans’ syndrome (ES) is defined as the concomitant or sequential association of warm auto-immune haemolytic anaemia (AIHA) with immune thrombocytopenia (ITP), and less frequently autoimmune neutropenia. ES is a rare situation that represents up to 7% of AIHA and around 2% of ITP. When AIHA and ITP occurred concomitantly, the diagnosis procedure must rule out differential diagnoses such as thrombotic microangiopathies, anaemia due to bleedings complicating ITP, vitamin deficiencies, myelodysplastic syndromes, paroxysmal nocturnal haemoglobinuria, or specific conditions like HELLP when occurring during pregnancy. As for isolated auto-immune cytopenia (AIC), the determination of the primary or…

Pediatricsmedicine.medical_specialtyEvans syndromemedicine.medical_treatmentSplenectomylcsh:MedicineDiseaseReview03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesMedicineCytopeniabusiness.industryMyelodysplastic syndromeslcsh:RGeneral Medicinemedicine.diseaseEvans’ syndromeimmune thrombocytopenia030220 oncology & carcinogenesisConcomitantAutoimmune neutropeniaRituximabautoimmune haemolytic anaemiabusiness030215 immunologymedicine.drugJournal of Clinical Medicine
researchProduct

Outcome of Refractory Anemia with Ringed Sideroblasts Associated with Marked Thrombocytosis (RARS-T) In a Large Cohort of Patients

2010

Abstract Abstract 4113 Introduction: Most of the data related to RARS-T, a rare disorder, involve small cohorts of patients. We aimed to analyze more patients also considering a variety of myelodysplastic or myeloproliferative disorders. Objective: To compare a large cohort of patients with RARS-T to refractory anemia with ringed sideroblasts (RARS), refractory anemia with ringed sideroblasts and multilineage dysplasia (RARS-MD) or essential thrombocythemia (ET) at the time of diagnosis and during disease evolution, in terms of survival and complications. Materials: Data of a European multi-center study was used including 199 cases of RARS-T 173 cases of RARS, 102 cases of RARS-MD and 431 c…

Pediatricsmedicine.medical_specialtyThrombocytosisbusiness.industryEssential thrombocythemiaorganic chemicalsMyelodysplastic syndromesImmunologyCell BiologyHematologyRefractory anemia with ringed sideroblastsmedicine.diseaseBiochemistryGastroenterologybiological factorsbody regionsLeukemiaMyeloproliferative DisordersDysplasiaInternal medicineembryonic structuresmedicineHemoglobinbusinessneoplasmsBlood
researchProduct

Weyers acrodental dysostosis in a family.

1984

A four generation family with postaxial polydactyly of hands and feet and dental anomalies is reported. Lower and upper incisors were abnormal in shape and number. Additional findings were prominent ear anthelices, hypoplastic and dysplastic nails and mild shortness of stature. Inheritance was dominant with variable expression. It is proposed that the family presents the syndrome of acrofacial dysostosis described by Weyers in 1952. To differentiate it from other acrofacial dysostoses, we suggest naming the condition acrodental dysostosis.

Postaxial polydactylyMaleDental anomaliesNail dysplasiaWeyers acrodental dysostosisbusiness.industryTooth AbnormalitiesDysostosisAnatomyToesmedicine.diseaseDysostosesPedigreeVariable ExpressionFingersDysplastic nailsGeneticsmedicineHumansAbnormalities MultipleFemalebusinessChildGenetics (clinical)Clinical genetics
researchProduct

Heat shock proteins in hematopoietic malignancies

2012

Inducible heat shock proteins are molecular chaperones whose expression is increased after many different types of stress. They have a protective function helping the cell to cope with lethal conditions. Their basal expression is low in nonstressed, normal and nontransformed cells. However, in cancer cells and particularly in hematological malignancies, they are surprisingly abundant. Malignant cells have to rewire their metabolic requirements and therefore have a higher need for chaperones. This cancer cell addiction for HSPs is the basis for the use of HSP inhibitors in cancer therapy. HSPs have been shown to interact with different key apoptotic proteins. As a result, HSPs can essentiall…

ProteasesCell SurvivalCellular differentiationCellHSP27 Heat-Shock ProteinsApoptosisModels Biological03 medical and health sciences0302 clinical medicineHeat shock proteinmedicineAnimalsHumansHSP70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsHeat-Shock ProteinsCaspaseCell Proliferation030304 developmental biology0303 health sciencesbiologyCell DifferentiationCell BiologyNeoplasm Proteins3. Good healthCell biologyHaematopoiesismedicine.anatomical_structureApoptosisHematologic NeoplasmsMyelodysplastic Syndromes030220 oncology & carcinogenesisCancer cellbiology.proteinProtein Processing Post-TranslationalMolecular ChaperonesSignal TransductionExperimental Cell Research
researchProduct

Automatic differentiation of melanoma from dysplastic nevi.

2015

International audience; Malignant melanoma causes the majority of deaths related to skin cancer. Nevertheless, it is the most treatable one, depending on its early diagnosis. The early prognosis is a challenging task for both clinicians and dermatologist, due to the characteristic similarities of melanoma with other skin lesions such as dysplastic nevi. In the past decades, several computerized lesion analysis algorithms have been proposed by the research community for detection of melanoma. These algorithms mostly focus on differentiating melanoma from benign lesions and few have considered the case of melanoma against dysplastic nevi. In this paper, we consider the most challenging task a…

Shape featuresSkin Neoplasms[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/ImagingDysplastic02 engineering and technology[ INFO.INFO-CV ] Computer Science [cs]/Computer Vision and Pattern Recognition [cs.CV]030218 nuclear medicine & medical imagingColourPattern Recognition Automated0302 clinical medicine0202 electrical engineering electronic engineering information engineeringMelanoma[ SDV.IB.IMA ] Life Sciences [q-bio]/Bioengineering/ImagingRadiological and Ultrasound Technology[ INFO.INFO-IM ] Computer Science [cs]/Medical ImagingMelanomaClassificationComputer Graphics and Computer-Aided DesignDermoscopy imaging3. Good healthRandom forest020201 artificial intelligence & image processingComputer Vision and Pattern RecognitionAlgorithmsmedicine.medical_specialtyAutomatic differentiationFeature extractionHealth InformaticsDermoscopySensitivity and SpecificityDiagnosis Differential03 medical and health sciencesLesion analysisMachine learningImage Interpretation Computer-Assistedmedicine[INFO.INFO-IM]Computer Science [cs]/Medical ImagingHumansRadiology Nuclear Medicine and imagingTextureneoplasmsbusiness.industry[INFO.INFO-CV]Computer Science [cs]/Computer Vision and Pattern Recognition [cs.CV]medicine.diseaseDermatologySupport vector machineBag-of-words modelSkin cancerbusinessDysplastic Nevus SyndromeComputerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society
researchProduct